[GASMSIA] YoY Cumulative Quarter Result on 31-Dec-2017 [#4]

Stock
[GASMSIA] GAS MALAYSIA BERHAD
Announcement Date
15-Feb-2018
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2017
Quarter
31-Dec-2017 [#4]
Profit Trend
QoQ- 65.43%
YoY- 17.86%
Quarter Report
Latest QR
Upcoming QR
GASMSIA's Result
GASMSIA's Financial Summary
View:
Show?
Cumulative Result
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Revenue 6,686,868 6,886,453 6,233,243 5,348,821 4,052,969 3,619,769 2,773,462 15.78%
PBT 290,843 242,145 234,119 248,181 212,845 143,560 213,121 5.31%
Tax -78,221 -52,040 -53,727 -54,030 -48,425 -37,505 -45,493 9.44%
NP 212,622 190,105 180,392 194,151 164,420 106,055 167,628 4.03%
-
NP to SH 212,622 190,105 180,392 194,638 165,137 106,162 167,632 4.03%
-
Tax Rate 26.89% 21.49% 22.95% 21.77% 22.75% 26.12% 21.35% -
Total Cost 6,474,246 6,696,348 6,052,851 5,154,670 3,888,549 3,513,714 2,605,834 16.36%
-
Net Worth 1,080,100 1,042,993 1,024,118 1,050,312 1,020,137 970,703 1,012,947 1.07%
Dividend
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Div 123,905 123,264 115,560 102,720 102,720 106,186 115,560 1.16%
Div Payout % 58.28% 64.84% 64.06% 52.77% 62.20% 100.02% 68.94% -
Equity
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Net Worth 1,080,100 1,042,993 1,024,118 1,050,312 1,020,137 970,703 1,012,947 1.07%
NOSH 1,284,000 1,284,000 1,284,000 1,284,000 1,284,000 1,284,000 1,284,000 0.00%
Ratio Analysis
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
NP Margin 3.18% 2.76% 2.89% 3.63% 4.06% 2.93% 6.04% -
ROE 19.69% 18.23% 17.61% 18.53% 16.19% 10.94% 16.55% -
Per Share
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
RPS 520.78 536.33 485.46 416.57 315.65 281.91 216.00 15.78%
EPS 16.56 14.81 14.05 15.16 12.86 8.27 13.06 4.03%
DPS 9.65 9.60 9.00 8.00 8.00 8.27 9.00 1.16%
NAPS 0.8412 0.8123 0.7976 0.818 0.7945 0.756 0.7889 1.07%
Adjusted Per Share Value based on latest NOSH - 1,284,000
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
RPS 520.78 536.33 485.46 416.57 315.65 281.91 216.00 15.78%
EPS 16.56 14.81 14.05 15.16 12.86 8.27 13.06 4.03%
DPS 9.65 9.60 9.00 8.00 8.00 8.27 9.00 1.16%
NAPS 0.8412 0.8123 0.7976 0.818 0.7945 0.756 0.7889 1.07%
Price Multiplier on Financial Quarter End Date
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Date 31/12/20 31/12/19 31/12/18 29/12/17 30/12/16 31/12/15 31/12/14 -
Price 2.72 2.75 2.83 2.89 2.47 2.40 3.22 -
P/RPS 0.52 0.51 0.58 0.69 0.78 0.85 1.49 -16.07%
P/EPS 16.43 18.57 20.14 19.06 19.21 29.03 24.66 -6.53%
EY 6.09 5.38 4.96 5.25 5.21 3.45 4.05 7.02%
DY 3.55 3.49 3.18 2.77 3.24 3.45 2.80 4.03%
P/NAPS 3.23 3.39 3.55 3.53 3.11 3.17 4.08 -3.81%
Price Multiplier on Announcement Date
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Date 26/02/21 13/02/20 15/02/19 15/02/18 15/02/17 23/02/16 12/02/15 -
Price 2.63 2.82 2.82 2.70 2.76 2.47 3.14 -
P/RPS 0.51 0.53 0.58 0.65 0.87 0.88 1.45 -15.96%
P/EPS 15.88 19.05 20.07 17.81 21.46 29.87 24.05 -6.67%
EY 6.30 5.25 4.98 5.61 4.66 3.35 4.16 7.15%
DY 3.67 3.40 3.19 2.96 2.90 3.35 2.87 4.17%
P/NAPS 3.13 3.47 3.54 3.30 3.47 3.27 3.98 -3.92%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment